Table 2.
Clinical progress and outcome. Values are expressed as †median (range).
| Diazepam i.v. (n = 16) | Diazepam p.r. (n = 9) | |
|---|---|---|
| Admission Blantyre coma score† | 1 0 0 (0 0 0–2 2 1) | 0 1 0 (0 0 0–2 1 0) |
| 4 h Blantyre Coma Score (BCS)† | 1 1 0 (0 0 0–2 2 1) | 2 1 0 (0 0 0–2 2 1) |
| Decline in BCS at 4 h | 4 | 2 |
| Episode of hypoglycaemia | 2 | 3 |
| Transfusion | 3 | 2 |
| Convulsions before admission† | 3 (0–99) | 1 (0–99) |
| Prolonged convulsion (> 30 min) | 6 | 6 |
| Convulsions after admission† | 1 (0–28) | 3 (0–44) |
| Convulsion terminated with first DZ dose | 16 | 4 |
| Convulsions after treatment with first DZ† | 1 (1–28) | 3 (3–43) |
| 2nd dose of DZ or PAR | 9 | 7 |
| 3rd line treatment (PHEN) | 6 | 6 |
| Convulsion >30 min after treatment | 6 | 3 |
| Deaths | 0 | 1 |
| Gross neurological sequelae on discharge | 2 | 1 |